m6A Methylation in Regulation of Antiviral Innate Immunity

Author:

Karandashov Ivan1ORCID,Kachanov Artyom1,Dukich Maria12,Ponomareva Natalia134,Brezgin Sergey13ORCID,Lukashev Alexander1,Pokrovsky Vadim S.567ORCID,Chulanov Vladimir8ORCID,Kostyusheva Anastasiya1,Kostyushev Dmitry139ORCID

Affiliation:

1. Laboratory of Genetic Technologies, Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, First Moscow State Medical University (Sechenov University), 119048 Moscow, Russia

2. Faculty of Virology, Lomonosov Moscow State University, 119234 Moscow, Russia

3. Division of Biotechnology, Sirius University of Science and Technology, 354340 Sochi, Russia

4. Department of Pharmaceutical and Toxicological Chemistry, Sechenov First Moscow State Medical University, 119048 Moscow, Russia

5. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia

6. Blokhin National Medical Research Center of Oncology, 117198 Moscow, Russia

7. Faculty of Biochemistry, RUDN University, 117198 Moscow, Russia

8. Department of Infectious Diseases, First Moscow State Medical University (Sechenov University), 119048 Moscow, Russia

9. Faculty of Bioengineering and Biotechnologies, Lomonosov Moscow State University, 119234 Moscow, Russia

Abstract

The epitranscriptomic modification m6A is a prevalent RNA modification that plays a crucial role in the regulation of various aspects of RNA metabolism. It has been found to be involved in a wide range of physiological processes and disease states. Of particular interest is the role of m6A machinery and modifications in viral infections, serving as an evolutionary marker for distinguishing between self and non-self entities. In this review article, we present a comprehensive overview of the epitranscriptomic modification m6A and its implications for the interplay between viruses and their host, focusing on immune responses and viral replication. We outline future research directions that highlight the role of m6A in viral nucleic acid recognition, initiation of antiviral immune responses, and modulation of antiviral signaling pathways. Additionally, we discuss the potential of m6A as a prognostic biomarker and a target for therapeutic interventions in viral infections.

Funder

RSF

Ministry of Science and Higher Education of Russia

Academic leadership program Priority 2030

Publisher

MDPI AG

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3